Decreased β-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration

Journal of the Neurological Sciences

Volumn 237, Issue 1-2, 2005, Pages 61-65

  Noguchi, Moeko ^a   Yoshita, Mitsuhiro ^a   Matsumoto, Yasuko ^a   Ono, Kenjiro ^a   Iwasa, Kazuo ^a   Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Amyloid peptide42; Alzheimer's disease; Cerebrospinal fluid; Corticobasal degeneration; Phosphorylated tau protein; Progressive supranuclear palsy; Total tau protein

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIOCHEMISTRY; CEREBROSPINAL FLUID ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIAGNOSTIC ACCURACY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN PHOSPHORYLATION; TAUOPATHY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; BASAL GANGLIA DISEASES; FEMALE; GENOTYPE; HUMANS; MALE; NEURODEGENERATIVE DISEASES; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PHENOTYPE; ROC CURVE; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 25644432885     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.05.015     Document Type: Article

References (17)

1. 42 Arch Neurol 60 2003 1202 1206
2. (1-42) and tau levels in CSF Neurology 52 1999 1555 1562
3. 42 in the cerebrospinal fluid of patients with Alzheimer's disease Ann Neurol 38 1995 643 648
4. H. Arai, M. Terajima, M. Miura, S. Highchi, T. Muramatsu, and N. Machida Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease Ann Neurol 38 1995 649 652
5. 42 and phosphorylated tau protein as biomarkers for Alzheimer's disease Mol Neurobiol 24 2001 87 97
6. 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jacob disease Neurology 54 2000 1099 1102
7. 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of β-amyloid induced by disparate mechanisms Dement Geriatr Cogn Disord 13 2002 112 118
8. I. Litvan, Y. Agid, D. Calne, G. Campbell, B. Dubois, and R.C. Duvoisin Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop Neurology 47 1996 1 9
9. A.E. Lang, D.E. Riley, and C. Bergeron Cortical-basal ganglionic degeneration D.B. Calne Neurodegenerative diseases 1994 Saunders Philadelphia 877 894
10. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINDS-ADRDA Work Group under the auspices of Department of health and Human Service Task Force on Alzheimer's disease Neurology 34 1984 939 944
11. J. Chapman, J. Estupinan, A. Asherov, and L.G. Goldfarb A simple and efficient method for apolipoprotein E genotype determination Neurology 46 1996 1484 1485
12. M.I. Kamboh, R.E. Ferrel, and B. Kottke Genetic studies of human apolipoproteins V: a novel rapid procedure to screen apolipoprotein E polymorphism J Lipid Res 29 1998 1535 1543
13. 42 Neurology 62 2004 2116 2118
14. M. Higuchi, T. Ishihara, B. Zhang, M. Hong, A. Andreadis, and J.Q. Trojanowski Transgenic mouse model of tauopaties with glial pathology and nervous system degeneration Neuron 35 2002 433 446
15. J. Primavera, B.X. Lu, P.J. Riskind, M. Iulian, and S.M. DeLa Monte Brain accumulation of amyloid-beta in non-Alzheimer neurodegeneration J Alzheimers Dis 3 1999 183 193
16. 42 is reduced in multiple system atrophy but in normal in Parkinson's disease and proglessive supranuclear palsy Mov Disord 18 2003 186 190
17. K. Urakami, K. Wada, H. Arai, H. Sasaki, M. Kanai, and M. Shoji Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy J Neurol Sci 183 2001 95 98